Mesothelin-targeted agents in clinical trials and in preclinical development

Ronan J Kelly1, Elad Sharon, Ira Pastan

  • 1Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Abstract